How Inflammation Works

Your tissues are constantly monitored by specialized pattern-recognition receptors, molecular sensors that distinguish "self" from "non-self" and healthy from damaged. These receptors, found on tissue-resident immune cells like macrophages and mast cells, recognize two categories of alarm signals: PAMPs (pathogen-associated molecular patterns) from bacteria, viruses, and fungi, and DAMPs (damage-associated molecular patterns) released when your own cells are injured or dying. When a bacterial cell wall fragment binds to a Toll-like receptor, or when ATP leaks from a ruptured cell, these sensors undergo a shape change that triggers the alarm.

The recognition is remarkably specific—these receptors evolved to identify molecular signatures that indicate genuine threats rather than reacting to every harmless substance. A macrophage in your skin can distinguish between the lipopolysaccharide coating of dangerous gram-negative bacteria and the benign proteins of your own tissue. This detection system operates continuously, like security cameras scanning for intruders, so that the moment damage occurs—whether from a splinter piercing your finger or a virus invading your throat—the inflammatory response can begin within seconds.

Once threat-detection receptors activate, cells immediately release a cascade of signaling molecules—cytokines, chemokines, histamine, and prostaglandins—that transform the local environment. Histamine, dumped rapidly from mast cell granules, makes nearby blood vessels leaky and dilated within minutes. Prostaglandins, synthesized on-demand from membrane lipids, sensitize pain nerves and amplify the inflammatory signal. Cytokines like tumor necrosis factor (TNF) and interleukin-1 (IL-1) act as molecular bullhorns, alerting neighboring cells that danger is present.

These chemical messengers don't just broadcast locally—they create concentration gradients that guide reinforcements to the exact site of trouble. Chemokines establish chemical trails, with higher concentrations near the injury site, that immune cells follow like bloodhounds tracking a scent. The signals also reach the bloodstream, where they trigger systemic effects: your liver produces acute-phase proteins, your bone marrow releases more white blood cells, and your hypothalamus may raise your body temperature to create a less hospitable environment for pathogens.

The signaling system operates with precise timing and redundancy. Some molecules work within seconds, others ramp up over hours, and many reinforce each other's effects to ensure the message gets through. This redundancy means that blocking a single inflammatory signal rarely stops inflammation entirely—the system has multiple backup pathways to ensure threats don't go unanswered.

Inflammatory signals cause endothelial cells lining blood vessels to display sticky adhesion molecules on their surface, transforming the normally frictionless inner surface into something like Velcro. Neutrophils and other white blood cells flowing through capillaries begin to slow down, rolling along the vessel wall as their surface receptors weakly bind to these adhesion molecules. When a rolling neutrophil encounters the right combination of signals, it stops completely, squeezes between endothelial cells, and pushes through the vessel wall into the tissue—a process called extravasation.

Once in the tissue, immune cells navigate toward the injury site by following chemokine gradients, moving from areas of lower concentration toward higher concentration at the source. Neutrophils arrive first, typically within hours, because they're the most abundant white blood cells and respond to the earliest signals. Monocytes follow over the next day or two, transforming into macrophages once they reach the tissue. In a sprained ankle, millions of these cells migrate from blood vessels into the swollen joint space.

The recruitment isn't random—different signals attract specific cell types suited for particular threats. Bacterial infections recruit neutrophil swarms that excel at engulfing bacteria. Parasitic infections attract eosinophils specialized for large invaders. Viral infections bring in natural killer cells and T lymphocytes. This targeted recruitment ensures the inflammatory response matches the nature of the threat.

Neutrophils and macrophages are professional killers equipped with an arsenal of antimicrobial tools. They engulf pathogens and damaged tissue through phagocytosis, enclosing targets in internal compartments called phagosomes that fuse with lysosomes containing digestive enzymes and toxic chemicals. Inside these killing chambers, they unleash reactive oxygen species—highly unstable molecules that tear apart bacterial membranes and viral proteins. Neutrophils also release neutrophil extracellular traps (NETs), web-like structures of DNA and antimicrobial proteins that physically ensnare and kill bacteria outside the cell.

The attack phase is necessarily destructive—collateral damage to your own tissue is inevitable. The same reactive oxygen species that destroy bacteria also damage nearby healthy cells. Digestive enzymes released by dying neutrophils break down extracellular matrix proteins. This is why inflammation causes tissue damage: the cure is almost as destructive as the disease. A severe infection can leave permanent scars because the inflammatory attack destroyed not just pathogens but also structural tissue.

The inflammatory attack also establishes containment barriers. Fibrin proteins create meshworks that wall off infected areas, preventing pathogens from spreading through the body. Pus, despite its unpleasant appearance, represents a successful battlefield—a mixture of dead neutrophils, destroyed bacteria, and tissue debris confined to one area rather than circulating throughout your body. Without this aggressive attack-and-contain strategy, even minor infections could become life-threatening.

As pathogens are cleared, the inflammatory response must be actively shut down—it doesn't simply fade away. Macrophages that have finished engulfing debris undergo a dramatic transformation, switching from pro-inflammatory "M1" mode to anti-inflammatory "M2" mode that releases restorative signals like interleukin-10 and transforming growth factor-beta. These molecules suppress further immune cell recruitment, reduce chemical mediator production, and promote tissue repair. Specialized pro-resolving mediators—lipoxins, resolvins, and protectins—actively dismantle the inflammatory machinery.

Tissue repair begins while debris clearance is still ongoing. Fibroblasts migrate into the damaged area and deposit new collagen, creating a temporary scaffold. Blood vessels sprout new branches through angiogenesis, restoring circulation to damaged zones. Depending on the tissue type, stem cells or surviving tissue cells begin dividing to replace destroyed cells. In your skin, epithelial cells at wound edges multiply and migrate across the injury, eventually meeting in the middle to seal the surface.

The repair process determines the final outcome—complete restoration or permanent scarring. Tissues with regenerative capacity, like liver and bone, can reconstruct almost perfectly if inflammation resolves properly. Tissues with limited regeneration, like heart muscle, form collagen-rich scars that fill the gap but don't restore full function. Chronic inflammation—where the attack phase never properly transitions to repair—leads to progressive tissue destruction seen in diseases like rheumatoid arthritis and inflammatory bowel disease, where continuous damage accumulates because the repair phase never gets its turn.